AI Designer
Protocols translated into edit-check-ready eCRFs in minutes, not weeks.
Accelerate study start-up from weeks to days. Protocols translate into edit-check-ready eCRF drafts, lab reports ingest instantly, and audit-ready queries are drafted by AI — always reviewed, signed and locked by a qualified person.
Protocols translated into edit-check-ready eCRFs in minutes, not weeks.
Instant lab ingest: values lifted from central lab reports with full source-to-data traceability.
Every change attributed and time-stamped, designed for 21 CFR Part 11, CDSCO and DPDP.
Step by step breakdown
1Point the AI Designer at your protocol section. It instantly drafts the structured fields, validation logic and edit checks for CRA and DM review.
2Reading central lab report
Upload source documents or lab reports. AI Capture lifts values directly into fields, tagging every extraction with a confidence score for rapid verification.
Edit check
Visit 2 · Vital signs
Waiting for the data manager
Automated edit checks fire instantly as data lands. Discrepancies generate pre-drafted queries, saving data managers hours of manual tracking.
4Nothing goes live or locks without explicit human sign-off. Every signature is written to the trial's permanent audit trail.
Live, versioned, without a rebuild
The live study keeps running on its current version while the amendment is drafted, tested and signed beside it. No pause, no freeze, no migration.
v1.1 is drafted beside the live study. v1.0 keeps running at every site.09:12
Only what changed is exercised: entry, checks, derivations and export. Test data never touches production.10:40
Reviewer, timestamp and the value before and after go to the audit trail.12:05
v1.1 takes effect from its date. Sites keep entering, nothing is re-entered, nothing migrates.12:05
Nothing reaches a site without a qualified name on it. The live version is untouched.
A typical amendment: two fields, one edit check and a visit window. About three hours from amended protocol to live, with sites entering data throughout.
Drag fields onto the form, set the conditional logic and add edit checks. The AI is optional, and every draft it proposes can be taken apart the same way.
Your CTMS, eTMF, eConsent, RTSM and safety database connect once, at the boundary. Every field carries its SDTM mapping from the day it is designed, so statistics gets a clean handoff on the day of lock, not six weeks after it.
“Most systems we looked at were built for a trial that does not look like ours. Trialion starts from Schedule Y, and from what a coordinator at a remote site can realistically do on the day. The audit trail is the part that holds up when an inspector starts asking.”
Answered as we would answer them on a call, including the ones where the answer is not yet.
Today a study moves draft → UAT → live, and configuration is promoted between them. A separate development environment and an independent QC stage, with test subject data isolated from production, is the next piece of architecture we are building. If you are planning a build, ask us where it stands on the day.
Amendments version the study configuration and deploy without a rebuild. What we will not claim yet is a complete change-control workflow across separate environments, with a documented impact on already-enrolled subjects. Bring the scenario to the call and we will walk it honestly rather than demo around it.
They are two different things and we keep them separate. Platform validation is ours: the system is architected to GAMP 5 and the formal exercise runs with an external auditor. Study validation is proving that your CRFs, edit checks, derivations and visit structure behave to your specification — today that happens in UAT, and a dedicated QC stage with retained evidence is in build.
Yes. Roles and their permissions are configurable rather than fixed, at organisation, study and site level, because no two CROs use the same titles. Field- and form-level restriction is the next level of granularity and is not there yet.
Today it raises a query, and that is wrong — a deliberate blank is not a discrepancy. Standardised missing-data reasons (not done, not applicable, unknown, not available) recorded with a comment on the audit trail are a change we are making, because statistics needs to tell an omission from a fact.
No. A study can be built entirely by hand, and nothing the model drafts takes effect until a person accepts it. The AI writes a proposal; a qualified reviewer decides whether it becomes the study.
The generated output, every human change made to it afterwards, and who approved it are on the audit trail. Retaining the model version and the prompt alongside them is a change in progress, so an inspector can see what was proposed as well as what was accepted.
Not today. Trialion is built for open-label work, including bioequivalence and Phase I–IV designs that randomise without blinding. Blinding touches randomisation, drug supply, unblinded pharmacy roles and emergency unblinding at once, and we would rather say no now than ship something that leaks a treatment assignment.
Bring your protocol for a 30-minute walkthrough and have your sandbox live in 24 hours. No scoping call, no quote and no purchase order first.